《JAMA,3月12日,Supporting the Health Care Workforce During the COVID-19 Global Epidemic》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-03-14
  • Supporting the Health Care Workforce During the COVID-19 Global Epidemic

    James G. Adams, MD1,2; Ron M. Walls, MD3,4

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread internationally. Worldwide, more than 100?000 cases of coronavirus disease 2019 (COVID-19, the disease caused by SARS-CoV-2) and more than 3500 deaths have been reported. COVID-19 is thought to have higher mortality than seasonal influenza, even as wide variation is reported. While the World Health Organization (WHO) estimates global mortality at 3.4%, South Korea has noted mortality of about 0.6%.1-3

    Vaccine development and research into medical treatment for COVID-19 are under way, but are many months away. Meanwhile, the pressure on the global health care workforce continues to intensify. This pressure takes 2 forms. The first is the potentially overwhelming burden of illnesses that stresses health system capacity and the second is the adverse effects on health care workers, including the risk of infection.

  • 原文来源:https://jamanetwork.com/journals/jama/fullarticle/2763136?resultClick=1
相关报告
  • 《JAMA,3月19日,Securing the Safety Net and Protecting Public Health During a Pandemic Medicaid’s Response to COVID-19》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-03-20
    • Securing the Safety Net and Protecting Public Health During a Pandemic Medicaid’s Response to COVID-19 Chethan Bachireddy, MD, MSc1; Christopher Chen, MD, MBA2; Mohammad Dar, MD3 JAMA. Published online March 19, 2020. doi:10.1001/jama.2020.4272 The coronavirus disease 2019 (COVID-19) has exposed gaps in the social safety net in the US. Medicaid, which covers 71 million individuals, has an important responsibility in addressing these gaps. Medicaid programs can fund unexpected health care services that other insurance plans may exclude and are thus well-positioned to ensure that vulnerable patients have access to important health care services, and that hospitals and other health care organizations and clinicians are reimbursed for providing that care.
  • 《JAMA,3月13日,Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-03-14
    • Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy Early Experience and Forecast During an Emergency Response Giacomo Grasselli, MD1,2; Antonio Pesenti, MD1,2; Maurizio Cecconi, MD3 JAMA. Published online March 13, 2020. doi:10.1001/jama.2020.4031 On February 20, 2020, a patient in his 30s admitted to the intensive care unit (ICU) in Codogno Hospital (Lodi, Lombardy, Italy) tested positive for a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). He had a history of atypical pneumonia that was not responding to treatment, but he was not considered at risk for COVID-19 infection.1 The positive result was immediately reported to the Lombardy health care system and governmental offices. During the next 24 hours, the number of reported positive cases increased to 36. This situation was considered a serious development for several reasons: the patient (“patient 1”) was healthy and young; in less than 24 hours, 36 additional cases were identified, without links to patient 1 or previously identified positive cases already in the country; it was not possible to identify with certainty the source of transmission to patient 1 at the time; and, because patient 1 was in the ICU and there were already 36 cases by day 2, chances were that a cluster of unknown magnitude was present and additional spread was likely.